Skip to main content
BioNote, Inc. logo

BioNote, Inc. — Investor Relations & Filings

Ticker · 377740 ISIN · KR7377740006 KO Manufacturing
Filings indexed 160 across all filing types
Latest filing 2026-03-10 Proxy Solicitation & In…
Country KR South Korea
Listing KO 377740

About BioNote, Inc.

https://www.bionote.com/

BioNote, Inc. is a company specializing in in-vitro diagnostics for the animal health industry. It develops, manufactures, and distributes a range of veterinary diagnostic products, including rapid test kits, ELISA kits, point-of-care (POC) analyzers, and biomarker tests. The company's portfolio is based on its research and development of core biological components like antigens and antibodies. Its products are designed for the detection and diagnosis of animal diseases, providing veterinarians with tools for immunochemical and quantitative analysis in clinical settings.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Statement) for Bionote, Inc. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures, and proxy solicitation details. This document is a formal regulatory filing used to request shareholder votes for an AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2026-03-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Cho Byung-ki) of Bionote. This type of filing, which discloses personal share transactions or changes in ownership by company insiders, is classified as 'Director's Dealing' (DIRS) in the provided schema.
2026-03-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (증권선물위원회) and the Korea Exchange. It details share transactions (purchases) made by an executive (Park Cheol-se) of Bionote. This type of filing is standard for reporting insider trading/director dealings in the Korean market.
2026-03-10 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Changes in Shareholding by Major Shareholders and Others' (최대주주등소유주식변동신고서) for the company Bionote. It details specific transactions (stock option exercises and open-market purchases) by company executives and major shareholders. This type of filing, which reports personal share transactions by company insiders, is classified as 'Director's Dealing' (DIRS) in the provided schema.
2026-03-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. It details changes in share ownership by major shareholders and special related parties, including the purpose of holding (influencing management) and specific transaction details (stock options, market purchases). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-03-10 Korean
[기재정정]주식소각결정
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from Bionote regarding a 'Decision to Cancel Shares' (주식 소각 결정). It is a correction filing (정정신고) updating the scheduled date for the share cancellation. Since the document details a corporate action involving the reduction of shares (capital change/share cancellation), it falls under the category of share capital changes or corporate actions. Given the specific options, 'SHA' (Share Issue/Capital Change) is the most appropriate classification for announcements regarding changes to the company's share structure, including cancellations.
2026-03-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.